Mental health, smoking, harm reduction and quit attempts - a population survey in England.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
14 Aug 2020
Historique:
received: 27 02 2020
accepted: 28 07 2020
entrez: 16 8 2020
pubmed: 17 8 2020
medline: 20 8 2020
Statut: epublish

Résumé

Tobacco control strategies have engendered overall declines in smoking; however, a large gap remains between people with and without mental health problems, causing substantial health inequalities. Population-level information on barriers and opportunities for improvements is scarce. We aimed to assess mental health status of cigarette smokers and recent ex-smokers ('past-year smokers') in England, and smoking and harm reduction behaviour and quit attempts by mental health status. Data were collected from 5637 current and 434 recent ex-smokers in 2016/17 in household surveys of representative samples of adults. We calculated weighted prevalence of different indicators of mental health problem: a) ever diagnosis, b) none, moderate, serious past-month distress, c) past-year treatment. We compared weighted smoking status, cigarette type, dependence, motivation to stop smoking, cutting down, use of nicotine replacement therapy or e-cigarettes, short-term abstinence, and quit attempts according to mental health status. Among past-year smokers: 35.9% ever had a diagnosis; 24.3% had experienced moderate, an additional 9.7% serious, past-month distress; 21.9% had had past-year treatment. Those with an indication of a mental health problem were more highly dependent and more likely to smoke roll-your-own cigarettes but also more likely to be motivated to stop smoking, to cut down, use nicotine replacement therapy or e-cigarettes and to have attempted to quit in the past year. About a third of cigarette smokers in England have mental health problems. Interventions should address their increased dependence and leverage higher prevalence of harm reduction behaviours, motivation to stop and attempts to stop smoking.

Sections du résumé

BACKGROUND BACKGROUND
Tobacco control strategies have engendered overall declines in smoking; however, a large gap remains between people with and without mental health problems, causing substantial health inequalities. Population-level information on barriers and opportunities for improvements is scarce. We aimed to assess mental health status of cigarette smokers and recent ex-smokers ('past-year smokers') in England, and smoking and harm reduction behaviour and quit attempts by mental health status.
METHODS METHODS
Data were collected from 5637 current and 434 recent ex-smokers in 2016/17 in household surveys of representative samples of adults. We calculated weighted prevalence of different indicators of mental health problem: a) ever diagnosis, b) none, moderate, serious past-month distress, c) past-year treatment. We compared weighted smoking status, cigarette type, dependence, motivation to stop smoking, cutting down, use of nicotine replacement therapy or e-cigarettes, short-term abstinence, and quit attempts according to mental health status.
RESULTS RESULTS
Among past-year smokers: 35.9% ever had a diagnosis; 24.3% had experienced moderate, an additional 9.7% serious, past-month distress; 21.9% had had past-year treatment. Those with an indication of a mental health problem were more highly dependent and more likely to smoke roll-your-own cigarettes but also more likely to be motivated to stop smoking, to cut down, use nicotine replacement therapy or e-cigarettes and to have attempted to quit in the past year.
CONCLUSIONS CONCLUSIONS
About a third of cigarette smokers in England have mental health problems. Interventions should address their increased dependence and leverage higher prevalence of harm reduction behaviours, motivation to stop and attempts to stop smoking.

Identifiants

pubmed: 32795286
doi: 10.1186/s12889-020-09308-x
pii: 10.1186/s12889-020-09308-x
pmc: PMC7427923
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1237

Subventions

Organisme : Medical Research Council
ID : MR/S037519/1
Pays : United Kingdom
Organisme : UK Prevention Research Partnership
ID : MR/S037519/1
Organisme : Cancer Research UK
ID : C52999/A19748
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C1417/A22962
Pays : United Kingdom

Références

BMC Psychiatry. 2017 Jul 14;17(1):252
pubmed: 28705244
BMJ. 2013 May 21;346:f2539
pubmed: 23694688
Tob Control. 2020 Jan;29(1):29-35
pubmed: 30377242
Arch Gen Psychiatry. 2003 Feb;60(2):184-9
pubmed: 12578436
J Subst Abuse Treat. 2006 Oct;31(3):287-96
pubmed: 16996391
Int J Methods Psychiatr Res. 2012 Jun;21(2):88-97
pubmed: 22351472
Int J Methods Psychiatr Res. 2010 Jun;19 Suppl 1:61-87
pubmed: 20527006
Addict Behav. 2019 Mar;90:14-19
pubmed: 30352340
N Engl J Med. 2019 Feb 14;380(7):629-637
pubmed: 30699054
Int J Environ Res Public Health. 2013 Jan 28;10(2):446-61
pubmed: 23358230
Int J Environ Res Public Health. 2016 Dec 23;14(1):
pubmed: 28025560
Am J Prev Med. 2016 Dec;51(6):958-966
pubmed: 27522471
Drug Alcohol Depend. 1994 Feb;34(3):211-6
pubmed: 8033758
BMC Public Health. 2011 Jun 18;11:479
pubmed: 21682915
Am J Prev Med. 2017 Dec;53(6):810-817
pubmed: 29029966
Arch Gen Psychiatry. 1998 Feb;55(2):161-6
pubmed: 9477930
JAMA. 2000 Nov 8;284(18):2348-51
pubmed: 11066185
BMC Public Health. 2011 Apr 22;11:256
pubmed: 21513510
BMJ. 2014 Feb 13;348:g1151
pubmed: 24524926
Psychol Med. 2019 Apr;49(6):1033-1040
pubmed: 29986786
Drug Alcohol Depend. 2014 Mar 1;136:63-8
pubmed: 24417963
Nicotine Tob Res. 2020 Jan 27;22(1):130-134
pubmed: 30351429
JAMA. 2014 Jan 8;311(2):172-82
pubmed: 24399556
Lancet Psychiatry. 2019 May;6(5):379-390
pubmed: 30975539
Addiction. 2011 Mar;106(3):631-8
pubmed: 21134020
Drug Alcohol Depend. 2013 Feb 1;128(1-2):15-9
pubmed: 22943961
Psychol Med. 2003 Feb;33(2):357-62
pubmed: 12622315
BMC Med. 2020 Jun 25;18(1):161
pubmed: 32580770
Int J Methods Psychiatr Res. 2010 Jun;19 Suppl 1:4-22
pubmed: 20527002
Tob Control. 2014 Jul;23 Suppl 3:iii48-53
pubmed: 24824516
Br J Psychiatry. 2011 Dec;199(6):453-8
pubmed: 21593516
Addiction. 2009 May;104(5):719-33
pubmed: 19413788
J Subst Abuse Treat. 2013 Apr;44(4):375-83
pubmed: 23098381
BMC Public Health. 2013 Feb 12;13:128
pubmed: 23402478
Am J Public Health. 2014 Aug;104(8):1557-65
pubmed: 23948001
Psychol Med. 2002 Aug;32(6):959-76
pubmed: 12214795

Auteurs

Leonie S Brose (LS)

Addictions, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 4 Windsor Walk, London, SE5 8BB, UK. leonie.brose@kcl.ac.uk.
, SPECTRUM Consortium, UK. leonie.brose@kcl.ac.uk.

Jamie Brown (J)

, SPECTRUM Consortium, UK.
Research Department of Clinical, Educational and Health Psychology, University College London, 1-19 Torrington Place, London, WC1E 7HB, UK.
Department of Epidemiology and Public Health, University College London, 1-19 Torrington Place, London, WC1E 7HB, UK.

Debbie Robson (D)

Addictions, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 4 Windsor Walk, London, SE5 8BB, UK.
, SPECTRUM Consortium, UK.

Ann McNeill (A)

Addictions, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 4 Windsor Walk, London, SE5 8BB, UK.
, SPECTRUM Consortium, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH